Actemra 80 mg/4 mL injection Images
Generic Name: tocilizumab
This medication has been identified as Actemra 80 mg/4 mL injection. It is supplied by Genentech, Inc.
Actemra is used in the treatment of Giant Cell Arteritis; Cytokine Release Syndrome; Rheumatoid Arthritis; COVID-19; Juvenile Idiopathic Arthritis and belongs to the drug class interleukin inhibitors. Risk cannot be ruled out during pregnancy. Actemra 80 mg/4 mL injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Actemra
- Generic Name
- tocilizumab
- Strength
- 80 mg/4 mL injection
- Availability
- Prescription only
- Drug Class
- Interleukin inhibitors
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Genentech, Inc.
- National Drug Code (NDC)
- 50242-0135
More about Actemra (tocilizumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (45)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Support group
- FDA approval history
- Drug class: interleukin inhibitors
- Breastfeeding
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.